Increased accumulation of acidic fibroblast growth factor in left ventricular myocytes of patients with idiopathic cardiomyopathy - PubMed (original) (raw)

Increased accumulation of acidic fibroblast growth factor in left ventricular myocytes of patients with idiopathic cardiomyopathy

Y Tomita et al. Am Heart J. 1997 Oct.

Abstract

To clarify the pathophysiologic role of fibroblast growth factors in idiopathic cardiomyopathy, we evaluated endomyocardial biopsy specimens obtained from 24 patients (nine with hypertrophic cardiomyopathy [HCM], 12 with dilated cardiomyopathy [DCM], and three with hypertensive hypertrophy) and six controls. All the specimens were stained for acidic fibroblast growth factor (aFGF) and basic FGF (bFGF) with immunohistochemistry. In situ hybridization was carried out for detection of aFGF mRNA. The average diameter of the myocytes, the percent area of interstitial fibrosis, and capillary vessel density were assessed in each biopsy specimen with morphometric methods. Positive staining of aFGF was observed in the myocytes of the biopsy specimens taken from 15 of 21 (71%) patients with cardiomyopathy (six of nine HCM, nine of 12 DCM) and all hypertensive hypertrophy patients but in none of the controls (p < 0.01). The average diameter of the myocytes was significantly larger in the patients with positive aFGF staining than in those with negative staining (23.1 +/- 1.5 versus 18.3 +/- 1.2 microm, p < 0.05). The percent area of fibrosis and the density of capillaries did not differ between the two groups. Intense expression of aFGF mRNA was observed in the myocytes from the patients with positive aFGF protein. In conclusion, the expression of FGF was significantly increased in myocytes obtained from the left ventricle of patients with cardiomyopathy. Acidic FGF may contribute to the hypertrophy of myocytes as the repair response to myocardial injury in patients with idiopathic cardiomyopathy.

PubMed Disclaimer

Cited by

The "Angiogenic Switch" and Functional Resources in Cyclic Sports Athletes.
Balberova OV, Bykov EV, Shnayder NA, Petrova MM, Gavrilyuk OA, Kaskaeva DS, Soloveva IA, Petrov KV, Mozheyko EY, Medvedev GV, Nasyrova RF. Balberova OV, et al. Int J Mol Sci. 2021 Jun 17;22(12):6496. doi: 10.3390/ijms22126496. Int J Mol Sci. 2021. PMID: 34204341 Free PMC article. Review.
Genetic Dissection of Hypertrophic Cardiomyopathy with Myocardial RNA-Seq.
Gao J, Collyer J, Wang M, Sun F, Xu F. Gao J, et al. Int J Mol Sci. 2020 Apr 25;21(9):3040. doi: 10.3390/ijms21093040. Int J Mol Sci. 2020. PMID: 32344918 Free PMC article.
Fibroblast growth factor-2 mediates pressure-induced hypertrophic response.
Schultz JE, Witt SA, Nieman ML, Reiser PJ, Engle SJ, Zhou M, Pawlowski SA, Lorenz JN, Kimball TR, Doetschman T. Schultz JE, et al. J Clin Invest. 1999 Sep;104(6):709-19. doi: 10.1172/JCI7315. J Clin Invest. 1999. PMID: 10491406 Free PMC article.
Angiogenic Endothelial Cell Signaling in Cardiac Hypertrophy and Heart Failure.
Gogiraju R, Bochenek ML, Schäfer K. Gogiraju R, et al. Front Cardiovasc Med. 2019 Mar 6;6:20. doi: 10.3389/fcvm.2019.00020. eCollection 2019. Front Cardiovasc Med. 2019. PMID: 30895179 Free PMC article. Review.
Pathway analysis shows association between FGFBP1 and hypertension.
Tomaszewski M, Charchar FJ, Nelson CP, Barnes T, Denniff M, Kaiser M, Debiec R, Christofidou P, Rafelt S, van der Harst P, Wang WY, Maric C, Zukowska-Szczechowska E, Samani NJ. Tomaszewski M, et al. J Am Soc Nephrol. 2011 May;22(5):947-55. doi: 10.1681/ASN.2010080829. Epub 2011 Mar 24. J Am Soc Nephrol. 2011. PMID: 21436287 Free PMC article.

Increased accumulation of acidic fibroblast growth factor in left ventricular myocytes of patients with idiopathic cardiomyopathy - PubMed (original) (raw)